Irlanda - engleză - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - pimobendan - chewable tablet - 2.5 mg/tablet - pimobendan

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - pimobendan - chewable tablet - 5 mg/tablet - pimobendan

Emiratele Arabe Unite - engleză - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al amin united drug store germany - 1’s [1x3ml pre-filled syringe with ophthalmic cannula] - injection - 0.1% /3ml - n/a

Emiratele Arabe Unite - engleză - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al amin united drug store germany - 1’s [1x1.5ml pre-filled syringe with ophthalmic cannula] - injection - 0.1% 1.5ml - n/a

Emiratele Arabe Unite - engleză - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al amin united drug store germany - 1’s [1x3.0ml pre-filled syringe with ophthalmic cannula] - injection - 0.1% 3.0ml - n/a

Canada - engleză - Health Canada

boehringer ingelheim animal health canada inc. - pimobendan - tablet (chewable) - 10mg - pimobendan 10mg - dogs

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - for the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve regurgitation). (see also section “dosage, routes and method of administration”). for the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic with an increase in left ventricular end-systolic and end-diastolic diameter) in doberman pinschers following echocardiographic diagnosis of cardiac disease (see section “special warnings” and “precautions for use in animals”). for the treatment of dogs with myxomatous mitral valve disease (mmvd) in the preclinical stage (asymptomatic with a systolic mitral murmur and evidence of increased heart size) to delay the onset of clinical symptoms of heart failure (see section “special warnings” and “special precautions for use in animals”). do not use pimobendan in hypertrophic cardiomyopathies or in diseases in which an improvement in cardiac output cannot be achieved for functional or anatomical re

Israel - engleză - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - sugammadex as sodium - solution for injection - sugammadex as sodium 100 mg / 1 ml - sugammadex - sugamedin is indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - parenteral liquid/solution/suspension - pimobendan pyridazinone active 0.75 mg/ml - cardiovascular system

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 5.0 mg/tb - cardiovascular system